焦虑、恐惧与回避的临床特征及遗传机制:五种焦虑障碍综述
本文综述社交焦虑障碍、广泛性焦虑障碍、惊恐障碍、广场恐惧症和特定恐惧症中焦虑、恐惧与回避的交互作用,整合临床、神经心理、脑功能、治疗、遗传与表观遗传研究。基于焦虑与恐惧强度将五种障碍分为恐惧主导型、混合型和焦虑主导型三组,各组对应不同治疗策略,并提出按此分组进行GWAS可提高统计效力。
要点
- 五种焦虑障碍按焦虑/恐惧强度分为恐惧主导型(SP、AG)、混合型(PD、SAD)和焦虑主导型(GAD)。
- 恐惧主导型首选暴露疗法,混合型首选CBT兼顾暴露与认知重构,焦虑主导型可用SSRIs/SNRIs和CBT。
- 回避行为强度与起病年龄相关,早发型SP和SAD的回避可能受遗传因素影响更强。
核心结论
- 焦虑、恐惧与回避在五种焦虑障碍中交互作用,按焦虑/恐惧强度分组可指导治疗选择并提高遗传研究统计效力。
研究设计与样本
- 叙述性综述,整合五种焦虑障碍的临床、神经心理、脑功能、治疗、遗传与表观遗传研究。
主要发现
- 基于焦虑和恐惧强度将五种障碍分为恐惧主导型(SP、AG)、混合型(PD、SAD)和焦虑主导型(GAD)。
- 回避行为强度与起病年龄相关。
- 焦虑与恐惧由不同但相互作用的神经生物学机制调控,杏仁核是恐惧处理核心,HPA轴参与慢性焦虑调节。
- 遗传与表观遗传研究显示焦虑障碍有substantial heritability,遗传影响程度因焦虑、恐惧和回避而异。
- 早发型障碍(如SP和SAD)的回避行为可能受遗传因素影响更强。
关键数值与推荐
- 恐惧主导型:暴露疗法高效减少回避和恐惧反应,强调暴露的CBT有用。
- 混合型:CBT首选,兼顾暴露疗法和认知重构;SSRIs/SNRIs常用于减轻预期焦虑和恐惧症状。
- 焦虑主导型:SSRIs/SNRIs和强调认知重构的CBT对管理慢性担忧有效。
- 大规模GWAS分组焦虑障碍已识别共享遗传位点,但单个焦虑障碍的GWAS受样本量小限制。
临床怎么用
- 按焦虑/恐惧强度将患者分为恐惧主导型、混合型和焦虑主导型,匹配相应治疗策略。
- 恐惧主导型优先暴露疗法,混合型用CBT兼顾暴露与认知重构,焦虑主导型用SSRIs/SNRIs和认知重构CBT。
局限性
- 单个焦虑障碍的GWAS受样本量小限制。
- 本文为叙述性综述,未报告系统检索策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Anxiety disorders, including social anxiety disorder (SAD), generalized anxiety disorder (GAD), panic disorder (PD), agoraphobia (AG), and specific phobia (SP), are characterized by core features of excessive anxiety and fear. Furthermore, these disorders are often accompanied by avoidance behaviors. While avoidance is a common behavioral response, it may be a consequence of or a cocontributor to the anxiety and fear driving these disorders. This narrative review integrates the interactions among anxiety, fear, and avoidance behaviors across these five disorders and synthesizes findings from clinical, neuropsychological, brain function, treatment, genetic, and epigenetic studies. Based on the intensity of anxiety and fear, these anxiety five disorders can be categorized into three groups: fear-dominant (SP, AG), mixed (PD, SAD), and anxiety-dominant (GAD). The intensity of avoidance behaviors is related to the age of onset. Each group responds to different treatment approaches. In fear-dominant disorders, exposure therapy is highly effective in reducing avoidance behaviors and fear responses. Cognitive behavioral therapy (CBT) with an emphasis on exposure is useful. In the mixed group, CBT is the preferred treatment, with a focus on both exposure therapy and cognitive restructuring. In addition to CBT, selective serotonin and serotonin-norepinephrine reuptake inhibitors (SSRIs/SNRIs) are commonly used to reduce anticipatory anxiety and fear symptoms. In anxiety-dominant disorders, both SSRIs/SNRIs and CBT with an emphasis on cognitive restructuring are effective for managing chronic worry. Anxiety and fear are regulated by distinct but interacting neurobiological mechanisms, with the amygdala central to fear processing and the hypothalamic‒pituitary‒adrenal axis involved in chronic anxiety regulation. Genetic and epigenetic studies demonstrate substantial heritability across anxiety disorders, with varying degrees of genetic influence on anxiety, fear, and avoidance. Avoidance behaviors, particularly in early-onset disorders such as SP and SAD, may be more strongly influenced by genetic factors. Large-scale genome-wide association studies (GWASs) grouping anxiety disorders have identified shared genetic loci, but GWASs for individual anxiety disorders are limited by small sample sizes. Grouping anxiety disorders into broader categories - namely, fear-dominant, mixed, and anxiety-dominant - rather than considering each specific anxiety disorder in isolation may lead to increased statistical power and yield more comprehensive perspectives on the shared and distinct clinical and genetic risk factors among anxiety disorders.
引用
- Ohi K, Fujikane D, Takai K, et al. Clinical features and genetic mechanisms of anxiety, fear, and avoidance: A comprehensive review of five anxiety disorders. Mol Psychiatry. 2025. PMID: 40830577. doi:10.1038/s41380-025-03155-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。